glp-1 class drugs Agonists: A Comprehensive Overview GLP-1 agonist drugs show digestive
Description
Neurosci Lett 2008
Pratt et al
In a motion to exclude experts general causation reports and request for lawsuit dismissal, Novo Nordisk says that the plaintiffs five expert witnesses and their testimonies should be excluded
Association of GLP-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases
Concerns include reports of adverse events, some requiring hospitalization, that may be related to dosing errors or doses beyond what is in the FDA-approved drug label, which means using more product in a single dose, taking doses more frequently or increasing the amount more quickly (titration schedule)
